Author

Madison O’Brien

Institution: Frontier Science & Technology Research Foundation, Inc.

Observed institution: Frontier Science & Technology Research Foundation, Inc.

OpenAlex ID: A5159175232

Pharmacokinetics and safety of dolutegravir in term neonates exposed to HIV-1 (IMPAACT 2023): a phase 1, open-label, multicentre study

2026 · Jeremiah D Momper, Jiajia Wang, et al. · The Lancet HIV

Works count: 1

Citation count:

H-index:

I10-index: